Nasal Packing Devices Market Size, Share & Trends Analysis Report By Product (Injectable, Gel, Sprays, Dressings), By Type (Bioresorbable, Non-absorbable), By Region, And Segment Forecasts, 2022 - 2030

Report Overview

The global nasal packing devices market size was valued at USD 173.2 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.1% from 2022 to 2030. The rising prevalence of epistaxis, also known as nosebleeds, is the primary factor majorly responsible for the growing demand for the market. The Ear, Nose, Throat (ENT) devices industries witnessed the penetration of new technological advancements in the field of healthcare during the COVID-19 period. The nasal packing devices industry faces some challenges in terms of the complications caused by the devices. In order to overcome these challenges, variations of nasal packing have been adopted in the form of gels and sprays. 

The COVID-19 pandemic impacted the world, especially the healthcare sector due to the large inflow of patients and the risk of contracting the virus. To control the spread of the virus, healthcare professionals, hospitals, staff, and patients have to adhere to the contamination protocol. There was a significant increase in patient visits for epistaxis during the COVID-19 pandemic. According to a study by the Public Health Emergency COVID-19 Initiative, a conclusion was made that epistaxis may display as a presenting symptom of COVID-19. Another report by the U.K. Trainee Research Collaborative Network, Integrate, revealed that among the patients presenting with epistaxis during the pandemic, around 17% tested positive for COVID-19.

Nasal packing devices can be characterized as intranasal devices that are positioned to exert continuous local pressure on the nasal septum. Its use is indicated for epistaxis, commonly known as a nosebleed. Epistaxis results from the cooperation of various elements that harm the nasal mucosal covering, influence the vessel walls, or disturb the coagulability of the blood. Nasal packing is the second line of treatment for epistaxis, after the failure of cauterization. According to a study on nosebleeds conducted in the U.S., the occurrence is most common among children between the age of 2 to 10, and adults and elders between the age of 50 to 80, this age group also contributes to the majority. Hence, the increasing number of the elderly population is also contributing to market growth.

Nasal packing can be classified according to the type of epistaxis, which is anterior and posterior based on the location of the site of bleeding. Anterior nasal packing has more demand as anterior bleeding is more common among patients. Patients need to be admitted to the hospital for the application of posterior nasal packing. Nasal packing is suggested to be applied only when the site of bleeding is clearly identified. Nasal packing traditionally included a ribbon gauze applied with antibiotics, lubricant, or ointments. But the industry has significantly developed, the recent launches include foam-based nasal packing that can absorb liquid more than 30 times its weight. Once absorbed, the packing expands imposing pressure on the nasal walls which helps control the bleeding.

Product Insights

The spray segment dominated the market in terms of the revenue share of around 30.0% in 2021. Spray nasal packing is an upcoming product and is directly applied into the nasal cavity or onto cotton balls that are placed in the cavity. The types of nasal sprays available are saline and decongestant.

The gel packing segment is likely to witness the fastest growth rate over the forecast period. The recent developments and efficacy of gel production, owing to the high patient comfort and its hemostatic properties are expected to contribute to the segment growth. Gel and dressings are the most common and effective products for the treatment of nosebleeds. There are various dressing brands available in the market. MeroGel by Medtronic is one of the popular nasal dressings in the market. Injectable nasal packing is particularly indicated to avoid lateralization of the central turbinate and also nasal adhesions in the post-surgery period.

Type Insights

In 2021, the non-absorbable segment held a majority of the market share of around 55% in terms of revenue. The non-absorbable nasal packing devices is an already well-established and preferred by physicians and are also comparatively cheaper than the bioresorbable nasal packing devices. 

The bioresorbable segment is likely to witness the fastest growth rate over the forecast period owing to the rapid technological advancements and the increasing introduction of newer brands into the market. Bioresorbable nasal packing devices are much more convenient to the patients as there is much less pain and has more advantages than their counterpart segment.

Regional Insights

In 2021, North America dominated the market in terms of revenue share owing to the growing adoption of nasal packing devices to treat the ever-increasing numbers of epistaxis patients and the increasing number of market players in the region. Moreover, increased COVID-19 cases in the region further boosted the demand for nasal packing devices.

In the Asia Pacific, the market is projected to witness a promising growth rate in the forecast period from 2022 to 2030. This growth can be attributed to the increase in the number of nasal packing device manufacturers, high unmet needs, booming economy, and overall improving healthcare infrastructure, especially in developing countries such as China and India. In addition, the increased awareness about nasal packing devices and their applications attribute to the growth of the market.

Key Companies & Market Share Insights

Rapidly evolving technology and the demand for nasal packing products are continuously encouraging the market players to invest and focus heavily on research and development activities in order to develop new and innovative products. Moreover, the significant growth in the number of companies offering nasal packing devices with updated features is further contributing to the growth of the nasal packing devices market. During the forecast period, nasal packing device manufacturers are most likely to rely on new innovations, mergers, and acquisitions to strengthen their market position. For instance, In December 2014, Medtronic Inc. launched the NovaShield injectable and biofragmentable nasal packing stent. In August 2021, the company also announced its entry into a definitive agreement with Intersect ENT, where Medtronic will buy all outstanding shares in cash for USD 28.25 per share, valued at a total of USD 1.1 billion. Some of the prominent players in the nasal packing devices market include:

• Summit Health

• Smith & Nephew

• Stryker Corporation

• Medtronic plc.

• Network medical products ltd.

• Olympus

• Lohmann & Rauscher

• Meril Life Sciences Pvt Ltd.

• FABCO

• Aegis Lifesciences

Nasal Packing Devices Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the global nasal packing devices market report based on product, type, and region: 

• Product Outlook (Revenue, USD Million, 2017 - 2030)

  • Injectable

  • Gel

  • Spray

  • Dressings 

• Type Outlook (Revenue, USD Million, 2017 - 2030)

  • Bio-resorbable

  • Non-absorbable 

• Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

  • Latin America

    • Brazil

    • Mexico

  • Middle East & Africa

    • South Africa